Holidays in the Sun May Be Key to Tackling Vitamin D Deficiencies, Scottish Study Shows
Holidays abroad may hold the key to tackling Scotland’s vitamin D deficiency, a University of Edinburgh study suggests. The…
Articles by Patricia Silva, PhD
Woman with PML Linked to MS Therapy Successfully Treated with IL-2 Cytokine
A case report of a woman with relapsing-remitting multiple sclerosis (MS), who developed progressive multifocal leukoencephalopathy (PML) after natalizumab therapy, found that…
Sanofi Genzyme and Johns Hopkins Partner on MS Research Projects into Disease Progression
Sanofi Genzyme announced that it entered into a research collaboration with the Johns Hopkins School of Medicine to better understand the underlying…
#CMSC16 – Dr. Ellen Mowry, in Interview, Talks of Clinical Studies into Vitamin D and MS
With an interest multiple sclerosis (MS) before even starting college, Dr. Ellen Mowry has spent her entire research career investigating the disease. Her epidemiological studies…
National MS Society Honors LyondellBasell with ‘Circle of Distinction Award’ for Raising $1.4M
LyondellBasell, an established name in the plastics, chemical and refining industry, has been honored with the Circle of Distinction Award from…
Fluorosamine Seen to Boost Remyelination in MS Mouse Model by Blocking Scarring Molecules
AÂ substance called fluorosamine was seen to boost remyelination in mice by preventing the synthesis of chondroitin sulfate proteoglycans and by…
Severe Rebound Effects Found in ‘Relevant’ Number of MS Patients After Stopping Fingolimod
Rebound symptoms after stopping fingolimod (Gilenya) treatment affect a “clinically relevant” number of multiple sclerosis (MS) patients, a study by University of…
Prime Minister Trudeau Meets with MS Society of Canada in Show of Support for MS Awareness Month
Canadian Prime Minister Justin Trudeau and other lawmakers met with members of the multiple sclerosis (MS) community and the Multiple…
#CMSC16 – High Glutamate Levels in Brain Seen to Drive MS Progression
Patients with multiple sclerosis (MS) have increased levels of the neurotransmitter glutamate in their brains, lowering the levels of N-acetylaspartate…
Yoga and Aquatic Exercise Seen to Markedly Ease MS-related Depression and Fatigue
Exercises like yoga and aquatic programs can help ease some symptoms of multiple sclerosis (MS), especially fatigue, depression and paresthesia, researchers report in a…
Acthar Gel an Effective Treatment for MS Relapses at Lower Cost, Company Reports
Clinical results presented at the recent Academy of Managed Care Pharmacy (AMCP)‘s 2016 annual meeting in San Francisco showed that the…
CHMP Favors European Approval of Zinbryta (Daclizumab) to Treat Relapsing MS
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recently recommended marketing authorization to…
MS Society Awards UT Researcher $490K to Study Link Between Blood Flow and Cognition
The National Multiple Sclerosis Society has awarded Dr. Bart Rypma, an associate professor at the Center for BrainHealth at the …
$185M Gift to UCSF Will Support New Neurosciences Institute
A gift worth $185 million from Joan and Sanford I. Weill to the University of California San Francisco (UCSF) will allow the…
Measures of Subtle Movements While Standing Detects Neurologic Problems in MS Patients and Athletes with Concussions
Researchers at Purdue University have developed a method of identifying subtle oscillations in a person’s posture that mirror an excessive delay in…
Multiple Sclerosis Consortium Sets Up MS Clinical Trial Database of Patient Records for Research Use
The Multiple Sclerosis Outcome Assessments Consortium (MSOAC) is making available to qualified researchers a new database containing almost 2,500…
Cognitive Difficulties Known to MS Traced to Problems in Nerve Cell Activity in Hippocampus
In a study published in the International Neurology Journal, researchers showed that cognitive deficits, such as memory…
Gut Bacteria Affects Myelin Content and Induces MS-Like Depression in Mice, Study Reports
Researchers at the Center of Excellence for Myelin Repair, a part of Mount Sinai, reported that gut bacteria produce compounds that were…
MedDay’s MD1003, a Biotin, Shows ‘Remarkable’ Efficacy in Treating Inactive but Progressive MS in Clinical Trials
MedDay recently disclosed full study results from the MS-SPI and MS-ON Phase 2b/3 trials of its therapeutic candidate MD1003 in patients…
Cytokine Once Thought Only to Promote Inflammation Now Seen to Have Restorative Properties, Too
Researchers at the School of Medicine of the University of California (UC), Riverside, found that TNF-alpha, a factor known…
At-Home ‘Brain Training’ Program for MS Patients Reported to Improve Cognitive Skills by 29%
Multiple sclerosis patients using a cognitive remediation computer training program, part of a controlled trial by researchers from NYU Langone Medical…
#CMSC16 – MS Experts Agree on Benefits of Vitamin D Supplements, Despite Mostly Circumstantial Evidence
A roundtable discussion, provided as a webinar organized by the Consortium of Multiple Sclerosis Centers (CMSC) in advance of its June conference,…
Biogen and AbbVie Present New Data Showing Zinbryta, an RRMS Drug Candidate, Aids Cognition Without Immune Depletion
New data presented by Biogen and AbbVie at the recent 68th annual meeting of the American Academy of Neurology (AAN) showed that…
Lymphoma Drug, Rituximab, Highly Effective in Treating Relapsing MS, Study from Sweden Reports
Mabthera (rituximab), a widely approved drug for treating lymphoma and/or rheumatoid arthritis, is highly effective in treating multiple sclerosis (MS),…
National MS Society Welcomes Mud-Loving Runners to Tramp Through Its 5K ‘MuckFest MS’ Fundraiser
The National Multiple Sclerosis Society and Event360 announced the opening of the 2016 season of MuckFest MS, a 5K “mud run”…
#CMSC16 – Dr. Fred Lublin to Deliver Opening Lecture on MS Relapses and Their Impact on Patient Outcomes
The Consortium of Multiple Sclerosis Centers (CMSC) 2016 Annual Meeting will open with the John F. Kurtzke Memorial Lecture, “Do Relapses…
Sanofi Genzyme Presenting New Data on Its Approved and Investigational Multiple Sclerosis Treatments at AAN
Sanofi Genzyme will present new data on its approved multiple sclerosis (MS) treatments — Lemtrada (alemtuzumab) and Aubagio (teriflunomide) — at the 68th annual…
Innate Immunotherapeutics Fully Enrolls Phase 2 Study of Drug Candidate to Treat SPMS
Innate Immunotherapeutics, Ltd., announced that it has completed patient enrollment in its ongoing Phase 2B, placebo-controlled clinical trial assessing the efficacy and safety…
Teva to Present Pipeline Data on MS Treatments at Ongoing AAN Annual Meeting
Teva Pharmaceutical Industries, Ltd., announced that new data on four of its products, including an approved and a potential…
Genentech to Present New Data from Phase 3 Trials of Ocrevus in MS Patients at AAN Annual Meeting
Genentech announced that it will present new data from three Phase 3 clinical trials of its experimental multiple sclerosis (MS) therapy Ocrevus…